🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a 2-part, open-label, interventional study conducted in approximate...
Status
Completed
Location
Local Institution - 103
Start Date
2018-10-04
Trial ID
NCT03720366
Treatments Being Tested
The primary objectives of Phase 1 Dose Escalation/Part 1 Expansion are: * ...
Status
Completed
Location
City Of Hope
Start Date
2013-08-27
Trial ID
NCT01915498
Treatments Being Tested
This phase II study compares the order of treatment with ivosidenib or enas...
Status
Recruiting
Location
University of Colorado
Start Date
2022-09-13
Trial ID
NCT05401097
Treatments Being Tested
Background: Cancers of the nasal cavity or skull base are rare. They often...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2024-03-04
Trial ID
NCT06176989
Treatments Being Tested
This is a multi-center, open-label study to assess the PK of single 100 mg ...
Status
Completed
Location
DaVita Clinical Research
Start Date
2017-09-21
Trial ID
NCT03290443
Treatments Being Tested
This research study is studying a targeted therapy drug as a possible treat...
Status
Completed
Location
Johns Hopkins Cancer Center
Start Date
2018-07-17
Trial ID
NCT03515512
Treatments Being Tested
This is a single-center, 2-part, open-label study to evaluate the metabolis...
Status
Completed
Location
Multiple Locations
Start Date
2015-05-14
Trial ID
NCT02443168
Treatments Being Tested
This is an open-label, single-center, randomized, three-period, two-sequenc...
Status
Completed
Location
PPD Development, LP
Start Date
2019-10-09
Trial ID
NCT04310527
Treatments Being Tested
This phase II MyeloMATCH treatment trial studies how well ASTX727 and venet...
Status
Recruiting
Location
Banner University Medical Center - Tucson
Start Date
2025-05-16
Trial ID
NCT06672146
This is a phase 1b/2, open-label, single arm study to evaluate if enasideni...
Status
Completed
Location
Stanford Cancer Institute
Start Date
2022-01-12
Trial ID
NCT05282459
Treatments Being Tested